Krystal Biotech Inc (KRYS)
177.11
+1.18
(+0.67%)
USD |
NASDAQ |
Oct 04, 16:00
175.01
-2.10
(-1.19%)
After-Hours: 20:00
Krystal Biotech Shareholders Equity (Annual): 778.64M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 778.64M |
| December 31, 2022 | 522.23M |
| December 31, 2021 | 593.58M |
| December 31, 2020 | 292.08M |
| Date | Value |
|---|---|
| December 31, 2019 | 202.91M |
| December 31, 2018 | 113.23M |
| December 31, 2017 | 49.47M |
| December 31, 2016 | 0.289M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
202.91M
Minimum
2019
778.64M
Maximum
2023
477.89M
Average
522.23M
Median
2022
Shareholders Equity (Annual) Benchmarks
| Bioventus Inc | 173.59M |
| ADMA Biologics Inc | 135.21M |
| Axsome Therapeutics Inc | 190.98M |
| Sarepta Therapeutics Inc | 859.34M |
| Janux Therapeutics Inc | 344.35M |